Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39-like pseudogene (ENSG00000228191; AL512326.4) is a human **pseudogene**—a nonfunctional DNA segment that shares high sequence homology with the functional *RPL39L* gene family, which encodes ribosomal proteins[1][4][7][2][5]. Pseudogenes like this do **not code for a functional protein product** and are not involved in biological processes typical of protein-coding genes[2][5]. While some pseudogenes can act as regulatory RNAs, there is no evidence that this specific pseudogene (ENSG00000228191) plays such a role[2][8]. It is **not considered a therapeutic target**, receptor, enzyme, or any other class of molecule commonly targeted by drugs in medicine or research. Based on reputable gene nomenclature databases and the functional definition of pseudogenes, this entry is most accurately characterized as **a nonfunctional copy of a ribosomal protein gene**; it is not a valid drug or therapeutic target and does not encode a receptor, enzyme, or any functionally relevant protein[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39-like pseudogene (RPL39L pseudogene).